16-56189980-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000501259.5(GNAO1-DT):​n.1115T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 151,992 control chromosomes in the GnomAD database, including 15,807 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 15807 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

GNAO1-DT
ENST00000501259.5 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.44

Publications

4 publications found
Variant links:
Genes affected
GNAO1-DT (HGNC:27543): (GNAO1 divergent transcript)
GNAO1 (HGNC:4389): (G protein subunit alpha o1) The protein encoded by this gene represents the alpha subunit of the Go heterotrimeric G-protein signal-transducing complex. Defects in this gene are a cause of early-onset epileptic encephalopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
GNAO1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • movement disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • neurodevelopmental disorder with involuntary movements
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000501259.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.564 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000501259.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNAO1-DT
NR_027078.2
n.1115T>C
non_coding_transcript_exon
Exon 1 of 5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNAO1-DT
ENST00000501259.5
TSL:1
n.1115T>C
non_coding_transcript_exon
Exon 1 of 5
GNAO1-DT
ENST00000569025.1
TSL:5
n.28T>C
non_coding_transcript_exon
Exon 1 of 2
GNAO1-DT
ENST00000662188.1
n.1139T>C
non_coding_transcript_exon
Exon 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
68953
AN:
151874
Hom.:
15806
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.411
Gnomad AMI
AF:
0.573
Gnomad AMR
AF:
0.469
Gnomad ASJ
AF:
0.397
Gnomad EAS
AF:
0.582
Gnomad SAS
AF:
0.386
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.463
Gnomad OTH
AF:
0.455
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.454
AC:
68977
AN:
151992
Hom.:
15807
Cov.:
32
AF XY:
0.455
AC XY:
33828
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.410
AC:
17004
AN:
41436
American (AMR)
AF:
0.469
AC:
7174
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.397
AC:
1377
AN:
3468
East Asian (EAS)
AF:
0.581
AC:
3004
AN:
5166
South Asian (SAS)
AF:
0.386
AC:
1858
AN:
4810
European-Finnish (FIN)
AF:
0.516
AC:
5445
AN:
10546
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.463
AC:
31477
AN:
67962
Other (OTH)
AF:
0.455
AC:
962
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1915
3830
5746
7661
9576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.456
Hom.:
20633
Bravo
AF:
0.454
Asia WGS
AF:
0.427
AC:
1484
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
12
DANN
Benign
0.81
PhyloP100
1.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4784642;
hg19: chr16-56223892;
COSMIC: COSV52613952;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.